- Report
- May 2025
- 50 Pages
Global
From €2451EUR$2,650USD£2,062GBP
The Styramate market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Styramate is a type of anticonvulsant drug used to treat epilepsy, a neurological disorder characterized by recurrent seizures. It is also used to treat other conditions such as bipolar disorder, anxiety, and depression. Styramate works by blocking certain receptors in the brain, which helps to reduce the frequency and severity of seizures.
Styramate is available in both generic and brand-name formulations. It is typically taken orally, but can also be administered intravenously. Common side effects of Styramate include drowsiness, dizziness, and blurred vision.
Some companies in the Styramate market include Pfizer, GlaxoSmithKline, Novartis, and Sanofi. Show Less Read more